Clinical Chemistry
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 43: 539-540, 1997;
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (11)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kaplan, B.
Right arrow Articles by Kahan, B. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kaplan, B.
Right arrow Articles by Kahan, B. D.
Related Collections
Right arrow Laboratory Management
Right arrow Evidence Based Laboratory Medicine and Test Utilization
Right arrow Drug Monitoring and Toxicology
(Clinical Chemistry. 1997;43:539-540.)
© 1997 American Association for Clinical Chemistry, Inc.

Technical Briefs

A Limited Sampling Strategy for Estimating Sirolimus Area-Under-the-Concentration Curve

Bruce Kaplan1,a, Herwig-Ulf Meier-Kriesche2, Kimberly Napoli2 and Barry D. Kahan

1 Div. of Renal Dis. and Hypertension, Dept. of Internal Med., and
2 Div. of Immunol. and Organ Transplant., Dept. of Surgery, The University of Texas Medical School at Houston, 6431 Fannin, Suite 4.163, Houston, TX 77030;
a author for correspondence and reprint requests: fax 713-794-1197

Sirolimus (SRL), a promising new immunosuppressive macrolide (1)(2)(3), displays unpredictable pharmacokinetic properties in humans. Measurement of a single trough concentration may reflect total drug exposure for drugs with consistent bioavailability and elimination properties, but not for drugs such as SRL that have variable bioavailability and unpredictable elimination characteristics. For such agents, area-under-the-concentration–time-curve (AUC) measurements have been used to estimate total drug exposure because they often correlate with pharmacodynamic effects (4)(5)(6). Although the relation between SRL AUC, the therapeutic effects of SRL, and toxicity has not been investigated, such a study might help elucidate the optimal therapeutic regimen for the drug.

Sampling regimens for full pharmacokinetic profiles are frequently not clinically feasible because of both time and cost restraints. Therefore, limited sampling strategies have been devised to obtain reasonable estimates of drug exposure. Limited sampling AUC strategies have been used to monitor the exposure of patients to oil-based (Sandimmune®; Sandoz, Basel, Switzerland) (7)(8) or microemulsion (Neoral®, Sandoz) (9) formulations of cyclosporine (CsA) and to chemotherapeutic agents such as cyclophosphamide (10). The present report describes a clinically reliable sampling strategy to predict the AUC values for SRL to more efficiently evaluate the clinical significance of total exposure.

In our study, 27 renal transplant recipients underwent a total of 77 full SRL pharmacokinetic profiles during the first year after the transplant procedure; 7 patients underwent pharmacokinetic profiling before the transplant procedure. SRL was administered once daily in a nonaqueous mixture (Rapamune®. . . [Full Text of this Article]


Acknowledgments


References




The following articles in journals at HighWire Press have cited this article:


Home page
 J Clin PharmacolHome page
D. Cattaneo, M. Cortinovis, S. Baldelli, E. Gotti, G. Remuzzi, and N. Perico
Limited Sampling Strategies for the Estimation of Sirolimus Daily Exposure in Kidney Transplant Recipients on a Calcineurin Inhibitor-Free Regimen
J. Clin. Pharmacol., July 1, 2009; 49(7): 773 - 781.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1997 by the American Association for Clinical Chemistry.